ClinicalTrialsFinder
RecruitingPhase 1Phase 2NCT04845217

Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome

Efficacy of Peppermint Oil in a Randomized, Single-Blind, Placebo Controlled Trial in Women With Interstitial Cystitis/Bladder Pain Syndrome

Sponsor

University of Louisville

Enrollment

100 participants

Start Date

Sep 15, 2021

Study Type

INTERVENTIONAL

Conditions

Interstitial Cystitis

Summary

The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Coconut Oil and a drug called Peppermint oil for people with interstitial cystitis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPeppermint oil

Enteric coated peppermint oil taken by mouth three times daily for 8 weeks.

DRUGCoconut Oil

Enteric coated coconut oil taken by mouth three times daily for 8 weeks

Locations(1)

Springs Medical Center

Louisville, Kentucky, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04845217

Related Trials

Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

NCT004993171 location

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

NCT060965971 location

Investigation of PEMF Therapy for Female Patients With IC/BPS

NCT051495731 location

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

NCT051276163 locations

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

NCT063948305 locations